483
OneBlood, Inc.FDA 483 - OneBlood, Inc. - June 06, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
OneBlood, Inc. in St Petersburg, FL, a blood bank, was cited for failing to submit biological product deviation reports within the required 45-day timeframe. An FDA review found 23 out of 282 reports were submitted late between December 2021 and June 2025. This issue is noted as a recurrent observation from a previous inspection.
Open in Dashboard
ID · e66f98eb-4c1d-4c90-9ab3-bb13ef45190e